Treatment-related alteration of cortisol predicts change in neuropsychological function during acute treatment of late-life anxiety disorder

International Journal of Geriatric Psychiatry

Volumn 27, Issue 5, 2012, Pages 454-462

  Lenze, Eric J ^a   Dixon, David ^a   Mantella, Rose C ^b   Dore, Peter M ^a   Andreescu, Carmen ^b   Reynolds III, Charles F ^b   Newcomer, John W ^c   Butters, Meryl A ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

antidepressant; anxiety; cortisol; memory; older; stress; treatment

Indexed keywords

ESCITALOPRAM; HYDROCORTISONE; PLACEBO;

ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; TREATMENT OUTCOME; WORKING MEMORY;

AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; BIOLOGICAL MARKERS; CITALOPRAM; DOUBLE-BLIND METHOD; EXECUTIVE FUNCTION; FEMALE; HUMANS; HYDROCORTISONE; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; SALIVA; SEROTONIN UPTAKE INHIBITORS;

EID: 84859890129     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2732     Document Type: Article

References (64)

1. Alexopoulos GS, Kiosses DN, Klimstra S, Kalayam B, Bruce ML,. 2002. Clinical presentation of the "depression-executive dysfunction syndrome" of late life. Am J Geriatr Psychiatry 10: 98-106.
2. Beaudreau SA, O'hara R,. 2008. Late-life anxiety and cognitive impairment: a review. Am J Geriatr Psychiatry 16: 790-803.
3. Beluche I, Chaudieu I, Norton J, et al,. 2009. Persistence of abnormal cortisol levels in elderly persons after recovery from major depression. J Psychiatr Res 43: 777-783.
4. Bierman EJ, Comijs HC, Jonker C, Beekman AT,. 2005. Effects of anxiety versus depression on cognition in later life. Am J Geriatr Psychiatry 13: 686-693.
5. Beluche I, Carriere I, Ritchie K, Ancelin ML,. 2010. A prospective study of diurnal cortisol and cognitive function in community-dwelling elderly people. Psychol Med 40: 1039-1049.
6. Bremmer MA, Deeg DJ, Beekman AT, et al,. 2007. Major depression in late life is associated with both hypo- and hypercortisolemia. Biol Psychiatry 62: 479-486.
7. Butters MA, Young JB, Lopez O, et al,. 2008. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci 10: 345-357.
8. Chaudieu I, Beluche I, Norton J, et al,. 2008. Abnormal reactions to environmental stress in elderly persons with anxiety disorders: evidence from a population study of diurnal cortisol changes. J Affect Disord 106: 307-313.
9. Butters MD, Bhalla RK, Andreescu C, et al,. 2011. Neuropsychological functioning in older adults with Generalized Anxiety Disorder. Br J Psychiatry, in press.
10. Comijs HC, Gerritsen L, Penninx BW, et al,. 2010. The association between serum cortisol and cognitive decline in older persons. Am J Geriatr Psychiatry 18: 42-50.
11. Conrad CD,. 2008. Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis. Rev Neurosci 19: 395-411.
12. Csernansky JG, Dong H, Fagan AM, et al,. 2006. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am J Psychiatry 163: 2164-2169.
13. Delis DC, Kaplan E, Kramer JH,. 2001. The Delis-Kaplan Executive Function System: Examiner's Manual. The Psychological Corporation: San Antonio, TX.
14. Diaconescu AO, Kramer E, Hermann C, et al,. 2010. Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression. Hum Brain Mapp, epub ahead of print.
15. Drueke B, Baetz J, Boecker M, et al,. 2009. Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study. Psychopharmacology (Berl) 207: 213-223.
16. Dumont GJ, De Visser SJ, Cohen AF, Van Gerven JM,. 2005. Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects. Br J Clin Pharmacol 59: 495-510.
17. Fava M, Graves LM, Benazzi F, et al,. 2006. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. J Clin Psychiatry 67: 1754-1759.
18. Fiocco AJ, Wan N, Weekes N, Pim H, Lupien SJ,. 2006. Diurnal cycle of salivary cortisol in older adult men and women with subjective complaints of memory deficits and/or depressive symptoms: relation to cognitive functioning. Stress 9: 143-152.
19. First MB, Spitzer RL, Gibbon M,. 1996. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), Clinician Version: Administration Booklet. American Psychiatric Press: Washington, DC.
20. Gallagher D, Coen R, Kilroy D, et al,. 2011. Anxiety and behavioural disturbance as markers of prodromal Alzheimer's disease in patients with mild cognitive impairment. Int J Geriatr Psychiatry 26: 166-172.
21. Gerritsen L, Comijs HC, Deeg DJ, Penninx BW, Geerlings MI,. 2009. Salivary cortisol, APOE-varepsilon4 allele and cognitive decline in a prospective study of older persons. Neurobiol Aging, epub ahead of print.
22. Hamilton M,. 1959. The assessment of anxiety states by rating. Br J Med Psychol 32: 50-55.
23. Het S, Ramlow G, Wolf OT,. 2005. A meta-analytic review of the effects of acute cortisol administration on human memory. Psychoneuroendocrinology 30: 771-784.
24. Hinkelmann K, Moritz S, Botzenhardt J, et al,. 2009. Cognitive impairment in major depression: association with salivary cortisol. Biol Psychiatry 66: 879-885.
25. Jayatissa MN, Bisgaard CF, West MJ, Wiborg O,. 2008. The number of granule cells in rat hippocampus is reduced after chronic mild stress and re-established after chronic escitalopram treatment. Neuropharmacology 54: 530-541.
26. Kim JJ, Diamond DM,. 2002. The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci 3: 453-462.
27. Le Roux H, Gatz M, Wetherell JL,. 2005. Age at onset of generalized anxiety disorder in older adults. Am J Geriatr Psychiatry 13: 23-30.
28. Lee BK, Glass TA, Mcatee MJ, et al,. 2007. Associations of salivary cortisol with cognitive function in the Baltimore memory study. Arch Gen Psychiatry 64: 810-818.
29. Lenze EJ, Mantella RC, Shi P, et al,. 2010. Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram. Am J Geriatr Psychiatry, epub ahead of print.
30. Lenze EJ, Mulsant BH, Mohlman J, et al,. 2005. Generalized anxiety disorder in late life: lifetime course and comorbidity with major depressive disorder. Am J Geriatr Psychiatry 13: 77-80.
31. Lenze EJ, Rollman BL, Shear MK, et al,. 2009. Escitalopram for older adults with generalized anxiety disorder: a placebo-controlled trial. JAMA 301: 296-303.
32. Lenze EJ, Wetherell JL,. 2009. Bringing the bedside to the bench, and then to the community: a prospectus for intervention research in late-life anxiety disorders. Int J Geriatr Psychiatry 24: 1-14.
33. Li G, Cherrier MM, Tsuang DW, et al,. 2006. Salivary cortisol and memory function in human aging. Neurobiol Aging 27: 1705-1714.
34. Lind K, Edman A, Nordlund A, Olsson T, Wallin A,. 2007. Increased saliva cortisol awakening response in patients with mild cognitive impairment. Dement Geriatr Cogn Disord 24: 389-395.
35. Lupien S, Lecours AR, Lussier I, et al,. 1994. Basal cortisol levels and cognitive deficits in human aging. J Neurosci 14: 2893-2903.
36. Mantella RC, Butters MA, Amico JA, et al,. 2008. Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder. Psychoneuroendocrinology 33: 773-781.
37. Mantella RC, Butters MA, Dew MA, et al,. 2007. Cognitive impairment in late-life generalized anxiety disorder. Am J Geriatr Psychiatry 15: 673-679.
38. Mcewen BS,. 1998. Protective and damaging effects of stress mediators. N Engl J Med 338: 171-179.
39. Mcewen BS,. 2008. Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 583: 174-185.
40. Middleton LE, Yaffe K,. 2009. Promising strategies for the prevention of dementia. Arch Neurol 66: 1210-1215.
41. Miller MD, Paradis CF, Houck PR, et al,. 1992. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 41: 237-248.
42. Naismith SL, Diamond K, Carter PE, et al,. 2010. Enhancing memory in late-life depression: the effects of a combined psychoeducation and cognitive training program. Am J Geriatr Psychiatry 19: 240-248.
43. Neumeister A, Wood S, Bonne O, et al,. 2005. Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects. Biol Psychiatry 57: 935-937.
44. Newcomer JW, Selke G, Melson AK, et al,. 1999. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 56: 527-533.
45. O'Brien JT, Lloyd A, Mckeith I, Gholkar A, Ferrier N,. 2004. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry 161: 2081-2090.
46. O'Hara R, Schroder CM, Mahadevan R, et al,. 2007. Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: association and interaction with cortisol. Mol Psychiatry 12: 544-555.
47. Peavy GM,. 2008. The effects of stress and APOE genotype on cognition in older adults. Am J Psychiatry 165: 1376-1378.
48. Peavy GM, Lange KL, Salmon DP, et al,. 2007. The effects of prolonged stress and APOE genotype on memory and cortisol in older adults. Biol Psychiatry 62: 472-478.
49. Peavy GM, Salmon DP, Jacobson MW, et al,. 2009. Effects of chronic stress on memory decline in cognitively normal and mildly impaired older adults. Am J Psychiatry 166: 1384-1391.
50. Penninx BW, Beekman AT, Bandinelli S, et al,. 2007. Late-life depressive symptoms are associated with both hyperactivity and hypoactivity of the hypothalamo-pituitary-adrenal axis. Am J Geriatr Psychiatry 15: 522-529.
51. Pollock BG,. 2005. The pharmacokinetic imperative in late-life depression. J Clin Psychopharmacol 25: S19-S23.
52. Potvin O, Hudon C, Dion M, Grenier S, Preville M,. 2010. Anxiety disorders, depressive episodes and cognitive impairment no dementia in community-dwelling older men and women. Int J Geriatr Psychiatry, in press.
53. Randolph C,. 1998. Repeatable Battery for the Assessment of Neuropsychological Status Manual. The Psychological Corporation: San Antonio, TX.
54. Reynolds CF, 3rd, Butters MA, Lopez O, et al,. 2011. Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch Gen Psychiatry 68: 51-60.
55. Rothman SM, Mattson MP,. 2010. Adverse stress, hippocampal networks, and Alzheimer's disease. Neuromolecular Med 12: 56-70.
56. Sheline YI, Gado MH, Kraemer HC,. 2003. Untreated depression and hippocampal volume loss. Am J Psychiatry 160: 1516-1518.
57. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW,. 1996. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 93: 3908-3913.
58. Stanley MA, Beck JG, Novy DM, et al,. 2003. Cognitive-behavioral treatment of late-life generalized anxiety disorder. J Consult Clin Psychol 71: 309-319.
59. Tata DA, Anderson BJ,. 2010. The effects of chronic glucocorticoid exposure on dendritic length, synapse numbers and glial volume in animal models: implications for hippocampal volume reductions in depression. Physiol Behav 99: 186-193.
60. Vythilingam M, Vermetten E, Anderson GM, et al,. 2004. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry 56: 101-112.
61. Wetherell JL, Reynolds CA, Gatz M, Pedersen NL,. 2002. Anxiety, cognitive performance, and cognitive decline in normal aging. J Gerontol B Psychol Sci Soc Sci 57: P246-P255.
62. Yehuda R, Golier JA, Kaufman S,. 2005. Circadian rhythm of salivary cortisol in holocaust survivors with and without PTSD. Am J Psychiatry 162: 998-1000.
63. Yehuda R, Harvey PD, Buchsbaum M, Tischler L, Schmeidler J,. 2007. Enhanced effects of cortisol administration on episodic and working memory in aging veterans with PTSD. Neuropsychopharmacology 32: 2581-2591.
64. Young AH, Gallagher P, Watson S, et al,. 2004. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology 29: 1538-1545.